Navigation Links
Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker
Date:12/3/2009

NEW YORK, Dec. 3 /PRNewswire/ -- Guidepoint Global, LLC, a leading primary research firm, today announced the launch of their Sleep Apnea Tracker, a monthly longitudinal data release that monitors and projects trends and market share in the worldwide Sleep Apnea market.

The Sleep Apnea Tracker captures actual patient usage for 87 different Sleep Apnea mask brands sold in the United States from 15 different equipment providers going back to January 2006. In the most recent dataset, over 46,000 Full Face Masks, Nasal Masks and Nasal Pillows/Prongs are captured, representing approximately 10% of the total market for Sleep Apnea masks. As a sign of the Tracker's historical accuracy and predictive utility, when Resmed Corporation (RMD) reported its results for the quarter ended September 30, 2009, it reported sequential quarterly growth in worldwide mask sales of 3.6% and year-over-year growth within North America of 23%. Over the same period, Guidepoint's Sleep Apnea Tracker mask data suggested 5.5% sequential growth and 19.3% growth year-over-year. The Sleep Apnea Tracker is available to subscribers through Guidepoint's online client portal, where current and historical data can be downloaded into users' proprietary models.

"Historically, Sleep Apnea has been a challenging area to follow, and anecdotal evidence of the state of the market was all people could rely on," said Maxim Jacobs, Senior Analyst at Guidepoint Global. "Guidepoint's new Sleep Apnea Tracker will provide followers of the Sleep Apnea market a more systematic way to analyze the area, and supply them with almost 4 years of historical data with which to extract lessons on the trajectory of new product launches within the market."

Guidepoint's Sleep Apnea Tracker will be its 27th Tracker, a collection of novel research products that monitor trends and market share in select medical technology and therapeutic industries. Information about the full suite of Trackers, covering areas including Cardiovascular Devices, Aesthetics, Ophthalmology, Dentistry, Therapeutics, Orthopedics and Hospital-based Capital Equipment, is available at http://www.guidepointglobal.com.

About Guidepoint Global, LLC

Guidepoint Global is a leading primary research firm founded in 2003 providing customized information solutions in the Healthcare, Technology, Media, Telecommunications, Energy, Industrials, Consumer Goods & Services, and Financial Services sectors. Clients include some of the world's leading private equity firms, mutual funds, hedge funds, strategy consultancies and multinational companies. Through phone consultations, face-to-face meetings, custom surveys, and proprietary data products, coupled with an industry-leading compliance platform, Guidepoint provides its clients with the insight required to make informed decisions.

SOURCE Guidepoint Global, LLC


'/>"/>
SOURCE Guidepoint Global, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
2. Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
3. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
4. Influenza is Leading Cause of Vaccine-Preventable Deaths for Kids; Despite CDC Recommendations, Moms Still Dont Vaccinate
5. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
6. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
7. Cleveland Clinic Leading Clinical Program to Improve Early-Stage Lung Cancer Detection
8. Leading AIDS Groups Turn Up The Heat on 08 Presidential Candidates
9. Clinical Experience With Peregrines Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents
10. Most Back Pain Could Be Cured Without Surgery or Drugs if Doctors Treated Muscles - Not the Spine - Says Leading Pain Specialist
11. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... DALLAS , April 19, 2017 /PRNewswire/ ... that the first patients in Nashville ... in the Lower Esophageal Sphincter Stimulation for GERD (LESS ... device designed to provide long-term reflux control by restoring ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)...  New research provides evidence that an old drug may ... study released today that will be presented at the ... Boston , April 22 to 28, 2017. ... disease, the oral drug levodopa has long been considered the ... the disease progresses, the effects of the medication can partially ...
(Date:4/18/2017)... Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device ... markets with innovative and proprietary products, will release financial ... after the market close on Tuesday, May 2, 2017. ... call and webcast to discuss its financial results the ... p.m. Eastern Time (3:30 p.m. Central Time). Darin ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab Physical ... be the preferred physical therapy provider for Derby City CrossFit, effective immediately. , ... CrossFit as quickly and effectively as possible, ProRehab’s sports physical therapists will work ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... to compare student test score performance for the 2015-16 school year across Wisconsin’s ... voucher programs. Though it highlights important patterns in student test score performance, the ...
(Date:4/25/2017)... Switzerland (PRWEB) , ... April 25, 2017 , ... ... innovation targets, they rely on contracted partners to help with process innovation in ... of combined drug formulation experience along with state-of-the-art analytical equipment in support of ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to ... of acute or chronic problems, I focus on preventative care with all my patients to ... have any questions, always feel free to contact my office and my trained staff will ...
(Date:4/25/2017)... ... , ... Vetoquinol USA® , a world-class developer of ... the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin ... , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and ...
Breaking Medicine News(10 mins):